MARENGO Trademark

Trademark Overview


On Friday, October 17, 2025, a trademark application was filed for MARENGO with the United States Patent and Trademark Office. The USPTO has given the MARENGO trademark a serial number of 99449951. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, October 17, 2025. This trademark is owned by MARENGO THERAPEUTICS, INC.. The MARENGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; v...
marengo

General Information


Serial Number99449951
Word MarkMARENGO
Filing DateFriday, October 17, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, October 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMARENGO THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, October 17, 2025NEW APPLICATION ENTERED
Friday, October 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 17, 2025APPLICATION FILING RECEIPT MAILED